Cargando…
Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report
We report a case of a patient with extensive-stage SCLC who developed acquired hemophilia A during maintenance atezolizumab therapy. The patient initially presented with asymptomatic anemia, a prolonged acquired prothrombin time, and factor VIII (FVIII) deficiency. Acquired FVIII autoantibodies were...
Autores principales: | Fletcher, James, Bird, Robert, McLean, Andrew J.W., O’Byrne, Kenneth, Xu, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579496/ https://www.ncbi.nlm.nih.gov/pubmed/36275909 http://dx.doi.org/10.1016/j.jtocrr.2022.100409 |
Ejemplares similares
-
Immune Checkpoint Inhibitors in Cancer Therapy
por: Shiravand, Yavar, et al.
Publicado: (2022) -
Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A
por: Jayasundara, Hishali D, et al.
Publicado: (2021) -
Acquired Hemophilia
por: Özsoylu, Şinasi
Publicado: (2014) -
Postpartum Acquired Hemophilia Factor VIII Inhibitors and Response to Therapy
por: Karakuş, Volkan, et al.
Publicado: (2012) -
Idiopathic Acquired Hemophilia A with Undetectable Factor VIII Inhibitor
por: Abt, Nicholas B., et al.
Publicado: (2014)